Big Phar­ma PACs blan­ket the elec­tion field with mil­lions in con­tri­bu­tions ahead of midterms

Phar­ma com­pa­nies may be up in arms with De­moc­rats over their re­cent­ly passed leg­is­la­tion to al­low Medicare to ne­go­ti­ate cer­tain ex­pen­sive drug prices, but their …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER